Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Ericson

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|April 22, 2015
Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist PharmacologyMark D Ericson, Andrzej Wilczynski, Nicholas B Sorensen, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor AgonistMark D Ericson, Romessa Shaikh, Courtney M Larson, et al.
Journal of Medicinal Chemistry|August 17, 2017
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 ReceptorMark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
ACS Chemical Neuroscience|June 21, 2018
Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist ProfilesMark D Ericson, Zoe M Koerperich, Katie T Freeman, et al.
ACS Omega|August 15, 2022
Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist TetrapeptideMark D Ericson, Courtney M Larson, Katie T Freeman, et al.
Molecules (Basel, Switzerland)|April 25, 2019
Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(<i>p</i>I)DPhe-Tic-NH<sub>2</sub> at the Mouse Melanocortin Receptors: Modification at the (<i>p</i>I)DPhe Position Leads to mMC3R Versus mMC4R Selective LigandsKatherine N Schlasner, Mark D Ericson, Skye R Doering, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 2, 2017
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016Mark D Ericson, Cody J Lensing, Katlyn A Fleming, et al.
ACS Chemical Neuroscience|May 3, 2016
Comparative Functional Alanine Positional Scanning of the α-Melanocyte Stimulating Hormone and NDP-Melanocyte Stimulating Hormone Demonstrates Differential Structure-Activity Relationships at the Mouse Melanocortin ReceptorsAleksandar Todorovic, Mark D Ericson, Ryan D Palusak, et al.
ACS Chemical Neuroscience|January 25, 2018
Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in MiceKatlyn A Fleming, Mark D Ericson, Katie T Freeman, et al.
Journal of Medicinal Chemistry|December 18, 2019
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor AntagonistsZoe M Koerperich, Mark D Ericson, Katie T Freeman, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|April 22, 2015
Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist PharmacologyMark D Ericson, Andrzej Wilczynski, Nicholas B Sorensen, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor AgonistMark D Ericson, Romessa Shaikh, Courtney M Larson, et al.
Journal of Medicinal Chemistry|August 17, 2017
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 ReceptorMark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
ACS Chemical Neuroscience|June 21, 2018
Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist ProfilesMark D Ericson, Zoe M Koerperich, Katie T Freeman, et al.
ACS Omega|August 15, 2022
Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist TetrapeptideMark D Ericson, Courtney M Larson, Katie T Freeman, et al.
Molecules (Basel, Switzerland)|April 25, 2019
Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(<i>p</i>I)DPhe-Tic-NH<sub>2</sub> at the Mouse Melanocortin Receptors: Modification at the (<i>p</i>I)DPhe Position Leads to mMC3R Versus mMC4R Selective LigandsKatherine N Schlasner, Mark D Ericson, Skye R Doering, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 2, 2017
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016Mark D Ericson, Cody J Lensing, Katlyn A Fleming, et al.
ACS Chemical Neuroscience|May 3, 2016
Comparative Functional Alanine Positional Scanning of the α-Melanocyte Stimulating Hormone and NDP-Melanocyte Stimulating Hormone Demonstrates Differential Structure-Activity Relationships at the Mouse Melanocortin ReceptorsAleksandar Todorovic, Mark D Ericson, Ryan D Palusak, et al.
ACS Chemical Neuroscience|January 25, 2018
Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in MiceKatlyn A Fleming, Mark D Ericson, Katie T Freeman, et al.
Journal of Medicinal Chemistry|December 18, 2019
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor AntagonistsZoe M Koerperich, Mark D Ericson, Katie T Freeman, et al.
Pageof 4